PT  - JOURNAL ARTICLE
AU  - Solange Bramer
AU  - Yvette Jaffe
AU  - Aravinth Sivagnanaratnam
TI  - Vestibular neuronitis after COVID-19 vaccination
AID  - 10.1136/bcr-2021-247234
DP  - 2022 Jun 01
TA  - BMJ Case Reports
PG  - e247234
VI  - 15
IP  - 6
4099  - http://casereports.bmj.com/content/15/6/e247234.short
4100  - http://casereports.bmj.com/content/15/6/e247234.full
SO  - BMJ Case Reports2022 Jun 01; 15
AB  - A woman in her 50s presented with acute vertigo and vomiting within 72 hours of receiving the Pfizer-BioNTech COVID-19 vaccine. The only neurological deficit was an impaired vestibulo-ocular reflex with horizontal nystagmus. The patient was subsequently diagnosed with vestibular neuronitis. She was managed symptomatically with prochlorperazine and betahistine, and underwent vestibular rehabilitation for 6 weeks. She made a full recovery and experienced no further symptoms. She received the second dose of the vaccine without complications.This case demonstrates a temporal association between COVID-19 vaccination and vestibular neuronitis. Neurological adverse events are rare but recognised side effects of COVID-19 vaccines and healthcare professionals should be aware of them. This ensures timely management of patients with such presentations. Treatment should be the same as for non-vaccine-associated vestibular neuronitis. The nature of the relationship between COVID-19 vaccination and vestibular neuronitis remains unclear and patients therefore require investigations to exclude other recognised causes of vestibular neuronitis.